000			01469cam a2200385 a 4500
001			13387640
003			OSt
005			20201123113758.0
008			031029s2003 nyua b 001 0 eng
010			_a 2003279593
020			_a9780824708382 (alk. paper)
040			_aDLC _cDLC _dDLC
043			_an-us---
050	0	0	_aRS189 _b.P46 2003
082	0	0	_a615.1/068/5 _222
100			_978 _aRobert A. Nash, Alfred H. Wachter.
245	0	0	_aPharmaceutical Process Validation _cedited by Robert A. Nash, Alfred H. Wachter.
250			_aInternational 3rd ed., rev. and expanded.
260			_aNew York : _bMarcel Dekker, _cc2003.
300			_axxxvi, 860 p. : _bill. ; _c24 cm.
490	1		_aDrugs and the pharmaceutical sciences ; _v129
504			_aIncludes bibliographical references and index.
650		0	_aPharmaceutical industry _xQuality control.
650		0	_aDrugs _xStandards _zUnited States.
650		2	_aDrug Evaluation _xstandards _zUnited States.
650		2	_aDrug Industry _xstandards _zUnited States.
650		2	_aQuality Control.
700	1		_aBerry, Ira R., _d1942-
700	1		_aNash, Robert A., _d1930-
830		0	_aDrugs and the pharmaceutical sciences ; _vv. 129.
856	4	2	_3Publisher description _uhttp://www.loc.gov/catdir/enhancements/fy0647/2003279593-d.html
906			_a7 _bcbc _corigcop _d2 _encip _f20 _gy-gencatlg
942			_2ddc _cBK
999			_c195 _d179